This is a research study for people diagnosed with AML. The purpose of this study is to see if the treatment of a combination of two drugs (cytarabine liposome therapy) and adding a third drug (pomalidomide) in different doses is more effective.

This is a study for people with colon, pancreatic, Squamous Non-small cell lung cancer, or Squamous cell carcinoma of head and neck. In this study, we want to find out if an investigational drug (Tisotumab Vedotin) is effective for people with solid tumors.

Do you currently have a solid tumor that has advanced or progressed after treatment with a PARP inhibitor? Does your tumor have genetic abnormalities in the system that repairs damage to DNA? If so, you may be able to take part in a research study to see if a new drug will be able to slow the growth of your cancer. Travel reimbursement and compensation provided if eligible for participation.

If you have been diagnosed with melanoma and need surgery to remove it, you may be able to take part in a research study. In this study, we want to learn whether a smaller incision during melanoma surgery is better or worse than the usual standard of care.

Do you have head and neck cancer or soft tissue sarcoma? Are you planning to have surgery to remove your tumor? You may be able to participate in a research study to determine which therapies may be best for future patients. Compensation provided.

The purpose of this study is to look at the effectiveness of a combination of treatments, polatuzumab vedotin with rituximab, gemcitabine, dexamethasone, and cisplatin (PV-RGDP) at treating relapsed or refractory diffuse large B-cell lymphoma.

This is a research study to find out which type of sedentary behavior, or sitting, is most strongly associated with cardiovascular disease (CVD) risk in endometrial cancer survivors. Additionally, we hope to better understand your perception of sedentary behavior and sedentary behavior reduction. The findings from this research study will be used to design a future sedentary behavior reduction intervention for endometrial cancer survivors. Participation in this study includes one assessment visit (during your regularly scheduled clinic visits) where we will measure your blood pressure and arterial stiffness using a blood-pressure like non-invasive device. Additionally, during this visit, you will answer questionnaires, complete a short physical function test (i.e., balance, walking, standing), and be instructed in how to use an accelerometer (movement tracking device worn on your upper thigh) paired with a smart-phone application that will ask you questions about your physical activities and sedentary behavior for 7-days following your

Do you have glioblastoma? Has your cancer either come back or did not improve after the treatments you received? If so, you may be eligible to participate in this gene therapy research study that wants to learn if a new way to modify your immune cells for use as possible treatment is safe and at what dose.

Do you have a type of cancer known as Nonseminmatous Germ Cell Tumor (NSGCT)? Has your cancer come back, or not get better with the last treatment you received? If so, you may be able to participate in a gene therapy study to see if we can use your body's own immune cells as a treatment for your NSGCT.

In this study, we will collect blood samples to help us learn if a blood test can be used to identify lung cancers. We also want to learn if a blood test can help us identify other types of cancers and health conditions.